Mustac E, Melato M, Sasso F, Valkovic T, Bottin C, Jonjic N
Department of Pathology, Medical Faculty, University of Rijeka, Croatia.
J Cancer Res Clin Oncol. 1996;122(11):693-7. doi: 10.1007/BF01209034.
The present study was designed to analyze the expression of lectin-binding sites for peanut agglutinin (PNA) in paraffin sections of primary invasive ductal carcinoma not otherwise specified and to consider PNA lectin histochemistry as a further aid in the prognostic evaluation of breast cancer. The expression of lectin-binding sites was studied using the avidin-biotin complex/ immunoperoxidase technique, and analyzed in relation to the different clinical, pathological, and biological parameters of the primary disease, i.e. the presence or absence of nodal metastases, pre- or post-menopausal age, size of the tumor, mitotic activity index, morphometric prognostic index, DNA content, S-phase fraction, and steroid receptor status. The results show significant differences in PNA binding patterns among malignant epithelial breast cells. There was no expression of PNA-binding sites in 14 out of 157 tumors, while 64 showed mostly apical (membrane) staining and 124 non-apical (membrane and/or cytoplasmic) staining. Apical staining was mostly observed in patients without lymph node metastasis, with positive steroid receptor status, and those who were postmenopausal diagnosis; non-apical staining was mostly observed in lymph-node-positive premenopausal patients negative for steroid receptors and with aneuploid tumor cells. Our results indicate that, in malignant breast cells, there is an alteration of cell-surface glycoconjugates, shown by heterogeneity within a histopathologically defined group, which is related to different properties of tumor cells. The apical PNA binding pattern indicates a better differentiation of tumor cells while non-apical PNA binding suggests a higher metastatic potential. Specific PNA lectin binding patterns should be considered as a further reliable prognostic factor in breast cancer.
本研究旨在分析普通型原发性浸润性导管癌石蜡切片中花生凝集素(PNA)凝集素结合位点的表达情况,并将PNA凝集素组织化学作为乳腺癌预后评估的进一步辅助手段。采用抗生物素蛋白-生物素复合物/免疫过氧化物酶技术研究凝集素结合位点的表达,并结合原发性疾病的不同临床、病理和生物学参数进行分析,即有无淋巴结转移、绝经前或绝经后年龄、肿瘤大小、有丝分裂活性指数、形态计量预后指数、DNA含量、S期分数和类固醇受体状态。结果显示,恶性乳腺上皮细胞的PNA结合模式存在显著差异。157例肿瘤中有14例未表达PNA结合位点,64例主要表现为顶端(膜)染色,124例表现为非顶端(膜和/或细胞质)染色。顶端染色多见于无淋巴结转移、类固醇受体状态阳性以及绝经后诊断的患者;非顶端染色多见于淋巴结阳性、绝经前、类固醇受体阴性且肿瘤细胞为非整倍体的患者。我们的结果表明,在恶性乳腺细胞中,细胞表面糖缀合物发生了改变,这在组织病理学定义的组内表现为异质性,与肿瘤细胞的不同特性相关。顶端PNA结合模式表明肿瘤细胞分化较好,而非顶端PNA结合提示转移潜能较高。特定的PNA凝集素结合模式应被视为乳腺癌进一步可靠的预后因素。